The effect of juevnille protective programs on protein aggregation during aging
Juevnille 保护计划对衰老过程中蛋白质聚集的影响
基本信息
- 批准号:8707303
- 负责人:
- 金额:$ 6.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-01 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdolescentAdultAffectAgeAge of OnsetAgingAlzheimer&aposs DiseaseAmyotrophic Lateral SclerosisAnimal ModelAnimalsAutophagocytosisBiological AssayBirthCaenorhabditis elegansCell Culture TechniquesCessation of lifeDementiaDevelopmentDiapauseDiseaseDown-RegulationFailureFunctional disorderGenesGeneticGoalsGrowthGrowth and Development functionHeat-Shock ResponseHomeostasisHumanHuntington DiseaseIndividualInheritedInsulinLaboratoriesLeadLifeLongevityMediatingModelingMolecular ChaperonesMotorMuscleMutateMutationNeurodegenerative DisordersNeuronal DysfunctionNeuronsOnset of illnessOrganismOxidative StressParalysedPathway interactionsPatientsPhenotypePhysiologicalPlayProductionPropertyProteinsRNA InterferenceReproductionResearchResearch PersonnelResistanceRiskRisk FactorsRoleSignal PathwaySignal TransductionStagingStressSymptomsTemperatureTestingTherapeuticTissuesToxic effectadvanced diseaseage relatedagedcell growthcell motilityegggenome-widehuman diseaseimprovedinnovationmutantnovel strategiesoverexpressionpolyglutaminepreventprogramsprotective effectprotein aggregateprotein aggregationprotein misfoldingpublic health relevancereproductivetreatment effect
项目摘要
DESCRIPTION (provided by applicant): Many late-onset neurodegenerative diseases, such as Huntington's disease (HD), Alzheimer's disease (AD) and Amyotrophic Lateral Sclerosis (ALS), are caused by the misfolding and aggregation of proteins. The ultimate risk factor for these diseases is aging. Also, in these diseases aggregate-prone proteins affect neurons, which increasingly lose function as the disease advances with age. Individuals stricken with these diseases succumb to the detrimental symptoms associated with them, such as dementia and loss of motor function and ultimately death. Currently, there are no cures for these diseases, and only few treatments to reduce the underlying symptoms are available. Ultimately, the production of more innovative therapeutic approaches will be most important for treatment, and hopefully cure, and understanding of the cellular and genetic pathways involved with protection against protein aggregation will help. In neurodegenerative diseases the aggregation-prone proteins are expressed at birth, although symptoms of disease are not present until later in life. Also, there exists great variability in age of onset among individuals who have the same genetically mutated protein. This suggests the presence of juvenile programs that can protect some resistant individuals later in life. Researchers have been studying known protective pathways that avoid or delay the failure of protein homeostasis (proteostasis) and thus delay or deduce toxic effects of protein aggregation. These approaches have found many ways to improve proteostasis, although often at the risk for delaying development and reproduction. Therefore, the goal of this research is to identify the pathways that act during juvenile stages to
protect against protein aggregation and are compatible with normal development, growth, and cellular signaling later in life. This will be accomplished by addressing the following questions: does transient passage through stress-resistant dauer stage protect against protein aggregation, and from phenotypes associated with proteotoxicity later in life? And ultimately, our goal is to identify the mechanisms that are protective during aging when activated in juveniles. Caenorhabditis elegans has a physiological protective program (dauer diapause) that is known to be stress-resistant and protected from aging. The above questions will be addressed by transiently activating dauer program early in life, subsequently allowing for normal development, and observing the effects of these treatments on protein aggregation and toxicity during aging.
描述(由申请人提供):许多迟发性神经退行性疾病,如亨廷顿氏病(HD)、阿尔茨海默病(AD)和肌萎缩侧索硬化症(ALS),都是由蛋白质的错误折叠和聚集引起的。这些疾病的最终风险因素是衰老。此外,在这些疾病中,易于聚集的蛋白质会影响神经元,随着疾病的发展,神经元会逐渐失去功能。患有这些疾病的人会出现与之相关的有害症状,如痴呆和运动功能丧失,最终死亡。目前,还没有治愈这些疾病的方法,只有很少的治疗方法可以减轻潜在的症状。最终,更创新的治疗方法的产生将是最重要的治疗,并希望治愈,并了解细胞和遗传途径参与保护蛋白质聚集将有助于。在神经退行性疾病中,易于聚集的蛋白在出生时表达,尽管疾病的症状直到生命后期才出现。此外,具有相同基因突变蛋白的个体在发病年龄上存在很大差异。这表明青少年项目的存在可以在以后的生活中保护一些有抵抗力的个体。研究人员一直在研究已知的保护途径,以避免或延迟蛋白质稳态(proteostasis)的失败,从而延迟或推断蛋白质聚集的毒性作用。这些方法已经找到了许多改善蛋白质平衡的方法,尽管往往有延迟发育和繁殖的风险。因此,本研究的目的是确定在幼年阶段起作用的途径
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jasmine Jancola Alexander-Floyd其他文献
Jasmine Jancola Alexander-Floyd的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jasmine Jancola Alexander-Floyd', 18)}}的其他基金
The effect of juevnille protective programs on protein aggregation during aging
Juevnille 保护计划对衰老过程中蛋白质聚集的影响
- 批准号:
8570789 - 财政年份:2013
- 资助金额:
$ 6.49万 - 项目类别:
相似海外基金
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 6.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The impact of changes in social determinants of health on adolescent and young adult mental health during the COVID-19 pandemic: A longitudinal study of the Asenze cohort in South Africa
COVID-19 大流行期间健康社会决定因素的变化对青少年和年轻人心理健康的影响:南非 Asenze 队列的纵向研究
- 批准号:
10755168 - 财政年份:2023
- 资助金额:
$ 6.49万 - 项目类别:
A Priority Setting Partnership to Establish a Patient, Caregiver, and Clinician-identified Research Agenda for Adolescent and Young Adult Cancer in Canada
建立优先合作伙伴关系,以建立患者、护理人员和临床医生确定的加拿大青少年和年轻人癌症研究议程
- 批准号:
480840 - 财政年份:2023
- 资助金额:
$ 6.49万 - 项目类别:
Miscellaneous Programs
Incidence and Time on Onset of Cardiovascular Risk Factors and Cardiovascular Disease in Adult Survivors of Adolescent and Young Adult Cancer and Association with Exercise
青少年和青年癌症成年幸存者心血管危险因素和心血管疾病的发病率和时间以及与运动的关系
- 批准号:
10678157 - 财政年份:2023
- 资助金额:
$ 6.49万 - 项目类别:
Fertility experiences among ethnically diverse adolescent and young adult cancer survivors: A population-based study
不同种族青少年和年轻成年癌症幸存者的生育经历:一项基于人群的研究
- 批准号:
10744412 - 财政年份:2023
- 资助金额:
$ 6.49万 - 项目类别:
Treatment development for refractory leukemia using childhood/adolescent, and young adult leukemia biobank
利用儿童/青少年和青年白血病生物库开发难治性白血病的治疗方法
- 批准号:
23K07305 - 财政年份:2023
- 资助金额:
$ 6.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular design of Two-Way Player CAR-T cells to overcome disease/antigen heterogeneity of childhood, adolescent, and young adult cancers
双向 CAR-T 细胞的分子设计,以克服儿童、青少年和年轻成人癌症的疾病/抗原异质性
- 批准号:
23H02874 - 财政年份:2023
- 资助金额:
$ 6.49万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Effects of adolescent social isolation on adult decision making and corticostriatal circuitry
青少年社会隔离对成人决策和皮质纹状体回路的影响
- 批准号:
10756652 - 财政年份:2023
- 资助金额:
$ 6.49万 - 项目类别:
Adolescent trauma produces enduring disruptions in sleep architecture that lead to increased risk for adult mental illness
青少年创伤会对睡眠结构产生持久的破坏,从而导致成人精神疾病的风险增加
- 批准号:
10730872 - 财政年份:2023
- 资助金额:
$ 6.49万 - 项目类别:
Using Tailored mHealth Strategies to Promote Weight Management among Adolescent and Young Adult Cancer Survivors
使用量身定制的移动健康策略促进青少年和年轻癌症幸存者的体重管理
- 批准号:
10650648 - 财政年份:2023
- 资助金额:
$ 6.49万 - 项目类别: